DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($28.85 B vs $28.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RMD | DXCM |
|---|---|---|
| Market cap | $28.08 B | $28.85 B |
| US-listed rank | #490 | #473 |
| Revenue (latest FY) | $5.15B | $4.66B |
| Net income (latest FY) | $1.40B | $836.30M |
| Net margin | 27.2% | 17.9% |
| P/E (trailing FY) | 20.0 | 34.5 |
| SEC filings | 2,518 | 2,566 |
DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($28.85 B vs $28.08 B).
In their latest fiscal years, RESMED INC reported $5.15B in revenue while DEXCOM INC reported $4.66B.
Full pages: RESMED INC and DEXCOM INC, or browse the full rankings.